Foresite Capital Management Iii, LLC Ardelyx, Inc. Transaction History

Foresite Capital Management Iii, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$1.66 - $4.16 $216,304 - $542,064	-130,304 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$3.7 - $5.8 $271,165 - $425,070	-73,288 Reduced 36.0%	130,304 $482,000
Q1 2018 May 15, 2018	BUY	$5.05 - $7.9 $1.03 Million - $1.61 Million	203,592 New	203,592 $1.03 Million
Q3 2017 Nov 13, 2017	SELL	$4.35 - $5.7 $163,125 - $213,750	-37,500 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	37,500	37,500 $191,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iii, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iii, LLC with notifications on news.